Joseph P. Hagan
2015 - Orexigen Therapeutics
In 2015, Joseph P. Hagan earned a total compensation of $1.3M as Former Chief Business and Financial Officer at Orexigen Therapeutics, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $103,181 |
|---|---|
| Option Awards | $806,973 |
| Salary | $375,205 |
| Other | $28,600 |
| Total | $1,313,959 |
Hagan received $807K in option awards, accounting for 61% of the total pay in 2015.
Hagan also received $103.2K in non-equity incentive plan, $375.2K in salary and $28.6K in other compensation.
Rankings
In 2015, Joseph P. Hagan's compensation ranked 6,616th out of 13,638 executives tracked by ExecPay. In other words, Hagan earned more than 51.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,616 out of 13,638 | 52nd |
Division Manufacturing | 2,482 out of 5,190 | 52nd |
Major group Chemicals And Allied Products | 899 out of 1,854 | 52nd |
Industry group Drugs | 722 out of 1,528 | 53rd |
Industry Pharmaceutical Preparations | 562 out of 1,182 | 53rd |
Source: SEC filing on May 27, 2016.
Hagan's colleagues
We found five more compensation records of executives who worked with Joseph P. Hagan at Orexigen Therapeutics in 2015.
2015
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2015
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
2015
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
2015
Heather Turner
Orexigen Therapeutics
General Counsel
2015
Thomas Lynch
Orexigen Therapeutics
General Counsel
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019